Lazard Asset Management
GMAB icon

Lazard Asset Management’s Genmab GMAB Stock Holding History

Lazard Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$209K Buy
+7,624
New +$203K ﹤0.01% 1661
2024
Q1 		– Sell
-879
Closed -$27K – 2172
2023
Q4 		$27K Sell
879
-1,097
-56% -$34.4K ﹤0.01% 2026
2023
Q3 		$69K Hold
1,976
– – ﹤0.01% 1761
2023
Q2 		$74K Buy
1,976
+234
+13% +$9.33K ﹤0.01% 1693
2023
Q1 		$64K Hold
1,742
– – ﹤0.01% 1710
2022
Q4 		$72K Sell
1,742
-74
-4% -$3.05K ﹤0.01% 1651
2022
Q3 		$56K Buy
1,816
+651
+56% +$22.9K ﹤0.01% 1752
2022
Q2 		$36K Sell
1,165
-508
-30% -$16.5K ﹤0.01% 1946
2022
Q1 		$59K Buy
1,673
+207
+14% +$7.1K ﹤0.01% 1659
2021
Q4 		$56K Buy
1,466
+196
+15% +$8.17K ﹤0.01% 1688
2021
Q3 		$54K Buy
1,270
+145
+13% +$6.51K ﹤0.01% 1650
2021
Q2 		$45K Buy
1,125
+202
+22% +$7.79K ﹤0.01% 1634
2021
Q1 		$30K Sell
923
-83
-8% -$3.12K ﹤0.01% 1645
2020
Q4 		$40K Sell
1,006
-167
-14% -$6.24K ﹤0.01% 1462
2020
Q3 		$42K Sell
1,173
-243
-17% -$8.79K ﹤0.01% 1233
2020
Q2 		$47K Sell
1,416
-1,652,241
-100% -$45M ﹤0.01% 1242
2020
Q1 		$35M Sell
1,653,657
-26,380
-2% -$588K 0.06% 205
2019
Q4 		$37.5M Sell
1,680,037
-14,084
-0.8% -$307K 0.05% 226
2019
Q3 		$34.3M Buy
+1,694,121
New +$33.4M 0.06% 233

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Lazard Asset Management's GMAB Position: Q2 2026 in Review

Lazard Asset Management opened a new position in Genmab (GMAB) in Q2 2026: 7,624 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #1661 among its holdings. This is a return to the name: Lazard Asset Management previously reported a position in GMAB as recently as Q4 2023.

Lazard Asset Management first reported a position in GMAB in Q3 2019 and has held it in 19 quarters since. The position peaked at $37.5M in Q4 2019. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Lazard Asset Management held 7,624 shares of Genmab worth $209K as of Q2 2026.
  • Genmab was a new Lazard Asset Management position in Q2 2026.
  • Genmab made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1661 holding.
  • Lazard Asset Management first reported a position in Genmab in Q3 2019 and has held it in 19 quarters since.
  • Lazard Asset Management's Genmab position peaked at $37.5M in Q4 2019.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.